Description

Alirinetide (GM604) is an oligopeptide containing 6 amino acids. Alirinetide can cross the blood-brain barrier and can be used for the research of multiple neurodegenerative diseases[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Neuroscience-Neurodegeneration–C36H54N12O9—-[1]Swindell W R, et al. GM604 for Parkinson’s Disease treatment: Pre-clinical findings and results from a pilot placebo-controlled trial. F1000Research, 2017, 6.–725715-18-4–798.89–99.73–OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](C)C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CO)NC([C@@H](N)CC2=CC=CC=C2)=O)=O)=O–Neurological Disease–DMSO : 100 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)–Others—-Others–Peptides